Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588133074> ?p ?o ?g. }
- W2588133074 endingPage "3180" @default.
- W2588133074 startingPage "3168" @default.
- W2588133074 abstract "Abstract Purpose: To explore factors associated with response and resistance to anti–PD-1 therapy, we analyzed multiple disease sites at autopsy in a patient with widely metastatic melanoma who had a heterogeneous response. Materials and Methods: Twenty-six melanoma specimens (four premortem, 22 postmortem) were subjected to whole exome sequencing. Candidate immunologic markers and gene expression were assessed in 10 cutaneous metastases showing response or progression during therapy. Results: The melanoma was driven by biallelic inactivation of NF1. All lesions had highly concordant mutational profiles and copy number alterations, indicating linear clonal evolution. Expression of candidate immunologic markers was similar in responding and progressing lesions. However, progressing cutaneous metastases were associated with overexpression of genes associated with extracellular matrix and neutrophil function. Conclusions: Although mutational and immunologic differences have been proposed as the primary determinants of heterogeneous response/resistance to targeted therapies and immunotherapies, respectively, differential lesional gene expression profiles may also dictate anti–PD-1 outcomes. Clin Cancer Res; 23(12); 3168–80. ©2017 AACR. See related commentary by Wilmott et al., p. 2921" @default.
- W2588133074 created "2017-02-24" @default.
- W2588133074 creator A5001682484 @default.
- W2588133074 creator A5004669792 @default.
- W2588133074 creator A5012118376 @default.
- W2588133074 creator A5014494747 @default.
- W2588133074 creator A5022931646 @default.
- W2588133074 creator A5027048828 @default.
- W2588133074 creator A5034640824 @default.
- W2588133074 creator A5035471137 @default.
- W2588133074 creator A5036118290 @default.
- W2588133074 creator A5043757838 @default.
- W2588133074 creator A5050595848 @default.
- W2588133074 creator A5052980036 @default.
- W2588133074 creator A5053532132 @default.
- W2588133074 creator A5061674061 @default.
- W2588133074 creator A5065218418 @default.
- W2588133074 creator A5066707073 @default.
- W2588133074 creator A5071088476 @default.
- W2588133074 creator A5076615388 @default.
- W2588133074 creator A5077237326 @default.
- W2588133074 creator A5080546333 @default.
- W2588133074 creator A5083171910 @default.
- W2588133074 date "2017-06-14" @default.
- W2588133074 modified "2023-10-16" @default.
- W2588133074 title "Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy" @default.
- W2588133074 cites W1498931318 @default.
- W2588133074 cites W1570009082 @default.
- W2588133074 cites W1834835434 @default.
- W2588133074 cites W1950829641 @default.
- W2588133074 cites W2020541351 @default.
- W2588133074 cites W2039123767 @default.
- W2588133074 cites W2044433401 @default.
- W2588133074 cites W2049553585 @default.
- W2588133074 cites W2057893793 @default.
- W2588133074 cites W2091189056 @default.
- W2588133074 cites W2097795961 @default.
- W2588133074 cites W2099432296 @default.
- W2588133074 cites W2103056281 @default.
- W2588133074 cites W2103441770 @default.
- W2588133074 cites W2104885590 @default.
- W2588133074 cites W2108371618 @default.
- W2588133074 cites W2109485845 @default.
- W2588133074 cites W2134471382 @default.
- W2588133074 cites W2138601221 @default.
- W2588133074 cites W2143772132 @default.
- W2588133074 cites W2148930557 @default.
- W2588133074 cites W2150575159 @default.
- W2588133074 cites W2150926065 @default.
- W2588133074 cites W2152061559 @default.
- W2588133074 cites W2156375592 @default.
- W2588133074 cites W2158217645 @default.
- W2588133074 cites W2160834915 @default.
- W2588133074 cites W2164992866 @default.
- W2588133074 cites W2165178639 @default.
- W2588133074 cites W2168133698 @default.
- W2588133074 cites W2168420784 @default.
- W2588133074 cites W2169895148 @default.
- W2588133074 cites W2187668060 @default.
- W2588133074 cites W2203677081 @default.
- W2588133074 cites W2230124910 @default.
- W2588133074 cites W2253928581 @default.
- W2588133074 cites W2299181842 @default.
- W2588133074 cites W2314266733 @default.
- W2588133074 cites W2340636398 @default.
- W2588133074 cites W2405513305 @default.
- W2588133074 cites W2435243879 @default.
- W2588133074 cites W2465860350 @default.
- W2588133074 cites W2512088483 @default.
- W2588133074 cites W2529978013 @default.
- W2588133074 cites W2560367415 @default.
- W2588133074 doi "https://doi.org/10.1158/1078-0432.ccr-17-0270" @default.
- W2588133074 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5474192" @default.
- W2588133074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28193624" @default.
- W2588133074 hasPublicationYear "2017" @default.
- W2588133074 type Work @default.
- W2588133074 sameAs 2588133074 @default.
- W2588133074 citedByCount "62" @default.
- W2588133074 countsByYear W25881330742017 @default.
- W2588133074 countsByYear W25881330742018 @default.
- W2588133074 countsByYear W25881330742019 @default.
- W2588133074 countsByYear W25881330742020 @default.
- W2588133074 countsByYear W25881330742021 @default.
- W2588133074 countsByYear W25881330742022 @default.
- W2588133074 countsByYear W25881330742023 @default.
- W2588133074 crossrefType "journal-article" @default.
- W2588133074 hasAuthorship W2588133074A5001682484 @default.
- W2588133074 hasAuthorship W2588133074A5004669792 @default.
- W2588133074 hasAuthorship W2588133074A5012118376 @default.
- W2588133074 hasAuthorship W2588133074A5014494747 @default.
- W2588133074 hasAuthorship W2588133074A5022931646 @default.
- W2588133074 hasAuthorship W2588133074A5027048828 @default.
- W2588133074 hasAuthorship W2588133074A5034640824 @default.
- W2588133074 hasAuthorship W2588133074A5035471137 @default.
- W2588133074 hasAuthorship W2588133074A5036118290 @default.
- W2588133074 hasAuthorship W2588133074A5043757838 @default.
- W2588133074 hasAuthorship W2588133074A5050595848 @default.
- W2588133074 hasAuthorship W2588133074A5052980036 @default.